Tissue-Resident Memory B Cell
Also written: BRM (B resident memory), tissue-resident MBC. Scope: this page also carries the splenic marginal-zone and bone-marrow MBC compartments, which are anatomically defined memory niches rather than separate cell identities.
Overview
Most of what is known about B cell memory comes from MBCs that recirculate between secondary lymphoid organs and are therefore accessible in peripheral blood. A parallel compartment does not recirculate: MBCs that take up long-term residence in non-lymphoid tissue (lung, skin, gut, liver) or in specific microanatomical niches within lymphoid organs (lymph-node subcapsular sinus, splenic marginal zone, bone marrow). These cells are positioned to mount rapid, local recall responses at the site of pathogen re-entry (see Glaros2025 - Multilayered Identity of B Cell Memory, review).
Residency is inferred from the same criteria used for T cells: resistance to intravenous antibody labelling, parabiosis, pharmacological egress blockade (S1PR1 agonists), and the canonical retention signature CD69↑ / S1PR1↓.
Why this page exists in a dengue wiki. The liver section below documents somatically hypermutated, T-bet⁺ MBC-like cells generated through a GC-independent pathway and resident in liver tissue — in an infection model where germinal centers are absent. Hepatic involvement (AST/ALT >1000) is one of only two severe-dengue signs with a consensus operational definition across the literature (see Morra2018 - Defining Warning Signs and Severe Dengue), which makes a liver-resident atypical B cell compartment a mechanistically live question for dengue severity — though no dengue liver B cell data exist, and the precedent below is murine plus chronic-hepatitis-B human.
Key Points from Literature
-
★ Liver: GC-independent, somatically hypermutated, T-bet⁺ IgM⁺ MBC-like cells reside in the tissue. In murine Ehrlichia muris infection — a model in which GCs are absent in the spleen — somatically hypermutated IgM⁺T-bet⁺ MBC-like cells are found in both liver and spleen. Because GCs are absent, these cells are necessarily generated through a GC-independent pathway. They reside in the tissue (resistant to intravenous antibody labelling), persist after infection clearance, and repertoire analysis suggested approximately half of liver clones were liver-exclusive. Liver but not splenic MBCs expressed Cd69 (see Glaros2025 - Multilayered Identity of B Cell Memory, review, citing Trivedi 2019 Immunity — mouse infection model; audit entry #65).
-
Liver, human: atypical MBCs reported in chronic hepatitis B. Some human studies suggest the presence of atypical MBCs in the livers of chronic hepatitis B patients (see Glaros2025 - Multilayered Identity of B Cell Memory, review, citing human cohorts). This is the closest human analogue to the murine finding above and links the tissue compartment to the Atypical B Cell cluster. Migratory properties, generating mechanisms, and function all remain undetermined.
-
Lung is the best-characterized BRM niche. Influenza-specific MBCs persist in lung tissue and mount rapid local responses on reinfection, established by parabiosis, intravenous labelling, and S1PR1-agonist egress blockade. Lung BRMs show CD69 upregulation and S1PR1 downregulation, express CCR6 and CXCR3, and have transcriptional profiles distinct from splenic and lymph-node counterparts in both mice and humans while sharing features with the CD8⁺ tissue-resident memory T cell residency programme. Likely origins are mediastinal lymph nodes and inducible bronchus-associated lymphoid tissue (iBALT) (see Glaros2025 - Multilayered Identity of B Cell Memory, review).
-
Isotype is compartmentalized by tissue. After respiratory infection the lung BRM pool is predominantly IgA⁺ with a smaller IgG⁺ fraction; IgG⁺ MBCs are distributed across both lung and mediastinal LNs while IgA⁺ MBCs localize primarily within the lung parenchyma, spatially associated with IgA-secreting PCs and iBALT. Systemic immunization fails to induce lung IgA⁺ MBCs; intranasal immunization induces them effectively (see Glaros2025 - Multilayered Identity of B Cell Memory, review).
-
BRMs can respond without antigen specificity for the invading pathogen. Boosting experiments showed BRMs of diverse specificities — including those unrelated to the invading threat — are rapidly recruited to the site of infection, apparently to “screen” the local environment for cognate antigen. Recruitment is orchestrated by alveolar macrophages via an IFN-γ → CXCL9/CXCL10 → CXCR3 cascade. Strikingly, some of these BRMs differentiate into PCs in response to innate signals alone, without specificity for the current threat — a speed-over-precision trade-off (see Glaros2025 - Multilayered Identity of B Cell Memory, review, mouse).
-
★ A methodological caveat that generalizes across this wiki. Many BRM studies used Aicda-based fate mapping to infer germinal-center origin. Because AID-driven CSR and SHM also occur outside the GC, these systems do not definitively establish GC provenance — leaving the developmental composition of the BRM pool unresolved (review). This is the same inference error the wiki already guards against via William2002 - Extrafollicular Somatic Hypermutation in Autoimmune Mice and Kaneko2020 - GC Loss and TFH Block in COVID-19: AID activity marks CSR/SHM machinery, not GC transit.
-
Skin and gut. Skin: direct evidence for MBCs is lacking, but B cells including expanded and class-switched clones are found in the dermis; Staphylococcus epidermidis exposure induces dermal tertiary lymphoid structures with local CSR to IgG2b/IgG2c, showing localized humoral responses independent of secondary lymphoid organs. Gut: IgA⁺ MBCs are found in Peyer’s patches and mesenteric LNs a year after priming, are clonally related to lamina propria PCs, and contribute to PC pool replenishment. Whether either compartment contains bona fide resident memory remains formally unestablished (see Glaros2025 - Multilayered Identity of B Cell Memory, review).
-
Lymph node: microanatomy shapes recall quality. MBCs are strongly biased toward the outer follicular area near the subcapsular sinus (SCS) — a niche enriched for antigen and memory TFH — rather than distributed like naive B cells. MBCs in draining LNs reenter secondary GCs more efficiently than those in non-draining LNs, and transcriptional differences underpin the distinct localization patterns. Practical implication the review draws: whether a booster is given in the same arm or the opposite arm can influence the quality of the resulting response (see Glaros2025 - Multilayered Identity of B Cell Memory, review).
-
Splenic marginal zone: in humans, largely a memory compartment. Unlike rodents — where the MZ is thought to be mostly naive innate-like B cells that rapidly generate low-affinity IgM PCs — a large fraction of human MZ B cells are considered MBCs, judged by CD27 expression and by the fact that most carry BCRs that have undergone SHM. The review attributes the mouse–human discrepancy at least partly to laboratory mice being raised under low-microbial-exposure conditions; immunization studies show mice can generate MZ-phenotype MBCs after antigenic challenge. Long-lived anti-smallpox MZ-phenotype MBCs dominated the switched memory compartment in spleens decades after vaccination (see Glaros2025 - Multilayered Identity of B Cell Memory, review). Naive MZ B cell development depends critically on Notch signalling; MZ retention is mediated by S1PR1, CNR2, and CD97.
-
Bone marrow MBCs are distinct residents, not a mixing pool. IgM⁺ mature B cells with somatically hypermutated BCRs are present in human BM. In immunized mice, antigen-specific MBCs accumulate in BM and remain detectable more than a year post-immunization, carrying a transcriptional signature and BCR repertoire distinct from splenic MBCs — indicating incomplete exchange between the two compartments. BM MBCs express integrins α4β1 and α6β1 and sit in close contact with VCAM-1⁺ stroma (see Glaros2025 - Multilayered Identity of B Cell Memory, review).
-
Early-life-origin cells feed these niches. B cell clones generated within the first two weeks of life contribute substantially to antigen-experienced compartments across multiple organs in adulthood, most pronouncedly in mucosal tissue, and are enriched among splenic MZ B cells — suggesting the MZ may serve as a hub for early-life-origin memory (review; see Memory B Cell).
-
The nomenclature review is openly unhappy with the term “tissue-based memory” — and its two tissue-based rows are blood populations. It calls these cells “the ambiguously coined tissue-based memory cells”, and notes that with the possible exception of germinal centre cells, every human B cell population found in lymphoid tissue can also be demonstrated in peripheral blood. Table 1 carries two FcRL4⁺ rows: a CD27⁺ one (IgD⁻CD27⁺CD38ˡᵒCD24ˡᵒCD21⁻, FcRL4⁺FcRL5⁺) annotated “mucosal surveillance; exhausted memory; BCR hypo-responsive memory”, and a CD27⁻ DN one annotated “atypical/tissue-based memory” — i.e. the label straddles the CD27 line (see Sanz2019 - Consistent Classification of Human B Cell Populations, review — no original data).
Contradictions & Debates
- Is BRM developmental origin GC-dependent or GC-independent? Unresolved, and the field’s main tool for answering it (Aicda fate mapping) cannot settle it — see the methodological caveat above. The Ehrlichia liver model is the clearest GC-independent case precisely because GCs are absent, but it is one model in one organ.
- Do gut and skin contain genuine resident memory B cells? The review is explicit that this “remains to be formally established” for the gut, and that whether the cutaneous B cell response generates skin-resident memory “remains to be tested.”
- Is “bystander” PC differentiation a lung-specific adaptation or a general BRM property? The review raises both possibilities — an intrinsic feature of BRMs, or a locally instructed behaviour specific to highly vulnerable tissue — and does not resolve them.
Related Pages
Memory B Cell, Early Memory B Cell, Atypical B Cell, Age-Associated B Cell, T-bet, CXCR3, AID, IgA, IgM, CD27, Germinal Center, Extrafollicular Response, Plasmablast, Somatic Hypermutation